Filana Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Filana Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Filana Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Filana Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Filana Therapeutics Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Filana Therapeutics Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 31 Oct 2014 | Lorem |
| Pain Therapeutics to seek commercialisation partner for Fenrock transdermal fentanyl pain patch - CEO | 01 Oct 2014 | Hamish McDougall |
| Pfizer could start bioequivalence and human abuse studies of opioid Remoxy end of 2013/early 2014 - executive | 21 Aug 2013 | Jennifer C. Smith-Parker |
| Phosphagenics set to hear CRO pitches for oxycodone and oxymorphone trials, in partnering talks – CEO | 27 Feb 2013 | Jennifer C. Smith-Parker |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer